(Q57081488)
Statements
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial (English)
Gabrina Tragni
Fernando Ravagnani
Paul Chaplin
Nathaly Arndtz
Ingo Drexler
Giorgio Parmiani
Natale Cascinelli
Alessandro M Gianni
1 September 2003